📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Efficacy of sofosbuvir plus ribavirin with or without peginterferon-alfa in patients with hepatitis C virus genotype 3 infection and treatment-experienced patients with cirrhosis and hepatitis C virus genotype 2 infection. (2015)

First Author: Foster GR

Attributed to: Immunity in the face of diversity and the development of novel potent HCV vaccines funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1053/j.gastro.2015.07.043

PubMed Identifier: 26248087

Publication URI: http://europepmc.org/abstract/MED/26248087

Type: Journal Article/Review

Volume: 149

Parent Publication: Gastroenterology

Issue: 6

ISSN: 0016-5085